University Hospital Prof. Edgard Santos
Welcome,         Profile    Billing    Logout  
 2 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Brites, Carlos
DOLCE, NCT04880395: Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3

Completed
4
230
RoW
Intervention Arm: dolutegravir/lamivudine, Dovato, Comparator ARM: TDF/XTC plus Dolutegravir (XTC stand for lamivudine OR emtricitabine)
Fundación Huésped, ViiV Healthcare, Federal University of Bahia
HIV-1-infection
05/24
05/24
NCT04650399: A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents

Completed
3
750
RoW
Active, Placebo
Butantan Institute, Valneva Austria GmbH
Chikungunya
02/23
02/24
PREGNANT, NCT04808973: DTG Plus 3TC for Prophylaxis of Mother-to-child Transmission of HIV Infection in Pregnant Women

Completed
3
20
RoW
Dolutegravir plus lamivudine in a FDC
Fundação Bahiana de Infectologia, GlaxoSmithKline
HIV Infections, Pregnancy Related, Mother to Child Transmission
08/23
09/23
UNITY, NCT05597735: Assessment of the Efficacy and Safety of Tecovirimat in Patients with Monkeypox Virus Disease

Recruiting
3
150
Europe, RoW
Tecovirimat, Placebo
ANRS, Emerging Infectious Diseases, University Hospital, Geneva, Oswaldo Cruz Foundation, Fundacion Huesped, Buenos Aires, Argentina
Monkeypox, Mpox
03/25
08/26
DOVETAIL, NCT06497465: Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment

Not yet recruiting
3
150
RoW
Dolutegravir 50mg Tab, TIVICAY 50 mg, TIVICAY PD, Dolutegravir/Lamivudine 50 MG-300mg Oral Tablet [DOVATO], Dolutegravir plus Tenofovir disoproxil fumarate (TDF)/ lamivudine (3TC)
Johns Hopkins University, ViiV Healthcare
Tuberculosis, HIV
01/28
01/29
NCT05797662: A Study of Propranolol to Treat Kaposi Sarcoma

Not yet recruiting
2
25
RoW
Propranolol
AIDS Malignancy Consortium, National Cancer Institute (NCI)
Kaposi Sarcoma
08/28
08/29
CODE, NCT04326504: Dolutegravir and Clinical Outcomes Among ART-recipients in Brazil

Recruiting
N/A
5000
RoW
No intervention
Fundação Bahiana de Infectologia, University of New Mexico, Instituto Infectologia Evandro Chagas, Rio de Janeiro, Fundação de Medicina Tropical de Manaus, Hospital de Clinicas de Porto Alegre, Centro de Referência e Tratamento, CRT, São Paulo, SP, Hospital Partenon, Porto Alegre, Universidade Municipal de São Caetano do Sul, Universidade Federal do Rio Grande do Norte, Hospital Universitário Cassiano Antônio de Moraes/HUCAM, Hospital das Clínicas da Faculdade de Medicina de Ribeirao Preto/USP, Faculdade de Medicina de Botucatu, Unesp, Sociedade Campineira de Educação e Instrução - Campinas, Fundação Universidade de Caxias do Sul - FUCS/RS
HIV Infections, Clinical Outcomes, Adverse Drug Event, Effect of Drugs
12/24
02/25

Download Options